Cellular Origins is building scalable cell therapy automation manufacturing solution.
Cellular Origins brings advanced robotics automation to cell therapy for the first time, enabling scale production that is closed, highly repeatable, data-rich and secure. Our technology seamlessly integrates production equipment selected by cell therapy companies to create manufacturing capacity at any scale.
Introducing ConstellationTM.
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies (CGTs), has announced the launch of Constellation, its closed, configurable, robotic cell therapy automation platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023.
Read the press release
Space Efficient
30x
Reduction in Labour
16x
Reduction in Cost
51%
How we work together.
Define
Understand your process, needs and ambition
Establish ROl with Cellular Origins’ cell therapy automation
Define requirements and roadmap to delivery
Build
Develop your configuration to achieve requirements
Undertake system build(s)
Application testing at Cellular Origins
Deploy
Installation at your facility
Integration into MES
Qualification of system
Operation and scale
Automated operation of your process
Capacity expansion and feature addition via additional modules
Ongoing lifecycle support
As featured in:
Sign up for updates.
Stay up-to-date with Cellular Origins and our modular factory automation for cell and gene therapies.